Looking ahead, Amgen's management has revised its full-year guidance. Revenue expectations for 2024 have been tightened to a range of $32.8 billion to $33.8 billion, up slightly from the previous ...

Upcoming patent losses are looming large for a number of pharma giants, including Amgen. The company reported a strong 2024, with revenue increasing 19% from the year before to $33.4 billion and ...

Amgen revealed a positive third quarter of 2024, exceeding earnings expectations. Despite some challenges in its operational landscape, the quarter reflects ongoing strategic successes ...

My name is Julianne, and I will be your conference facilitator today for Amgen's fourth quarter and full year 2024 financial results conference call. All lines have been placed on mute to prevent ...

In early February, Amgen released financial results for the 4th quarter of 2024, which I was eagerly awaiting. In addition to demonstrating efficacy in the treatment of nasal polyps in Phase 3 ...